Overview

Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil Film-coated Tablets 10 mg/40 mg

Status:
COMPLETED

Trial end date:
2024-08-08

Target enrollment:

Participant gender:

Summary

Single dose oral bioequivalence study of Macitentan and Tadalafil film-coated tablets 10 mg/40 mg and 'PrOpsynvi®' Macitentan and Tadalafil film-coated tablets 10 mg/40 mg in healthy adult male subjects under fasting conditions.

Phase:

PHASE1

Details

Lead Sponsor:

Humanis Saglık Anonim Sirketi

Treatments:

macitentan